Company Update (NYSE:ACT): Eli Lilly wins UK Alimta drug patent case on appeal, shares jump

[Reuters – UK Focus] – Eli Lilly has won a patent case in the Court of Appeal in London over its blockbuster Alimta lung cancer drug, boosting prospects for future sales and dealing . . . → Read More: Company Update (NYSE:ACT): Eli Lilly wins UK Alimta drug patent case on appeal, shares jump Similar Articles: Market Update (NYSE:LLY): Eli Lilly wins UK Alimta drug patent case on appeal Company Update (NYSE:LLY): Eli Lilly loses Alimta drug patent case in Germany to Actavis Stock Update (NYSE:ACT): Eli Lilly loses Alimta drug patent case in Germany to Actavis